Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
True. As we discussed before, the mc is unusually low for this company.
Not a bad write up there, nothing too promotional IMO, there could have been more speculation about the Bioassaygen products that would have been 'pump-able' but the author stuck with the basic facts.
Also, no apparent frontloading over the past month prior to the release of the pick:
2013/12/27 0.015 0.015 0.015 0.015 5 0.015
2013/12/26 0.015 0.015 0.015 0.015 3,480 0.015
2013/12/25 - 0.010 0.010 - - -
2013/12/24 0.010 0.010 0.010 0.010 120 0.010
2013/12/23 - - - - - -
2013/12/20 0.010 0.010 0.010 0.010 50 0.010
2013/12/19 0.025 0.025 0.025 0.025 28,000 0.025
2013/12/18 - - - - - -
2013/12/17 0.010 0.010 0.010 0.010 400 0.010
2013/12/16 - - - - - -
2013/12/13 0.015 0.015 0.015 0.015 10,000 0.015
2013/12/12 0.013 0.013 0.013 0.013 8,100 0.013
2013/12/11 - - - - - -
2013/12/10 0.015 0.016 0.015 0.015 44,675 0.015
2013/12/09 - - - - - -
2013/12/06 0.014 0.030 0.014 0.025 118,000 0.025
2013/12/05 0.025 0.054 0.025 0.054 16,828 0.054
2013/12/04 - - - - - -
2013/12/03 0.011 0.011 0.011 0.011 775 0.011
2013/12/02 0.015 0.015 0.015 0.015 9,000 0.015
2013/11/29 0.011 0.011 0.011 0.011 5,000 0.011
Actually it wouldn't take much 'awareness' at all to move DND with the current share structure, however, I have never heard of OTCRockstar before so I have no idea what type of following they have.
From that link you provided their track record looks decent enough, IR_OG was a bust but everything else had volume well over the 3M average and had nice gains. Of course I have no idea if any other promoters were involved as well or it was just them.
It is time to end the year with one last profiled pick, and this new alert has all the profit potential I could ask for. This newsletter has one of the top rated track records in 2013 delivering consistent winning alerts producing monster triple and even quadruple digit gains. Our new pick for Monday is DNDT, get ready to end the year on a high note!
DNDT has a near perfect technical set-up. With a market cap of $44,463, a tiny float and a current PPS of just $.015 this play could provide BIG gains very fast! There is very little trading activity on this stock and it appears with increased awareness DNDT could quickly gain the attention of Wall Street.
The company has a wholly owned subsidiary that is ready to roll out a mobile wallet platform that will be used for everyday shopping in one of the worlds fastest growing economies! This
About DNDT - DND Technologies
(Current PPS. $.015)
Founded in 1997, DND Technologies ( Symbol: DNDT) is a publicly traded holding company that acquires, invests in, or partners with next generation start-ups and established businesses to bring new or improved products to market.
DNDT’s core competencies include acquiring or taking strategic financial positions in cutting-edge companies that have synergies in business-to-business and business-to-consumer products, and new technology opportunities that are targeted to resolving unmet consumer needs and emergent business domains.
DNDT has already taken a number of strategic and financial positions in research and development activities in both on-going and start-up businesses. In most of these areas, basic research has been completed and DNDT is in the process of obtaining intellectual property rights. Announcements will be made here as soon as project-specific funds and/or strategic partnerships are secured.
One of the most intriguing aspects of DNDT is their wholly owned subsidiary of Cinutri, a mobile supermarket shopping and payment business solution platform that allows users to use their mobile phones to remotely purchase goods from supermarkets.
After the completion of a very promising consumer demand survey, using a proprietary mobile payments technology platform and working in concert with a large network of Brazilian supermarkets, DND Technologies is preparing to launch a mobile supermarket shopping pilot project named Cinutri as an independent, wholly-owned, subsidiary in Brazil.
DND Technologies management believes that this will be a great project with an excellent profit potential which will contribute greatly to shareholder value.
Cinutri allows users to use their mobile phones to remotely purchase goods from supermarkets, and have those goods delivered to their homes immediately or at some other requested time period. After registering for the service, users will be able to buy their required products with a few strokes on their mobile phones without the need to go to the supermarket. After registration, the consumer will receive a link via SMS to download the application on their phone, or they can download it from the Apple Store or the Android Play Store. Payments for purchased items will automatically be deducted from debit/credit cards and bank accounts programmed in during registration by the user.
Market Outlook
The total addressable market for multi-platform app development is worth US $ 2.4bn in 2013. Cross-platform tools help developers to deliver their multi-platform app development projects more efficiently. DNDT is at the forefront of this technology in one of the largest growing markets in the world!
The key factor to winning a share of the mobile wallet is customer experience. Consumers want an intuitive experience that is well thought out and provides engagement. To be successful, the mobile wallet must meet and exceed consumer expectations; otherwise, it will be quickly dismissed.
The global mobile wallet market is forecasted to reach $1,602.4 billion in five years, growing at a compound annual growth rate of 30.7 percent from 2012 to 2018.
DNDT has also acquired all the inventory, other assets and the exclusive rights to distribute a pharmaceutical line of products in the United States, Canada and Europe.
Rebranded by DNDT, the inventory of products includes Bioassaygen Gel, Bioassaygen Cosmetic Mask, Bioassaygen Bio-Skin, and Bioassaygen Delivery Gel, all of which will henceforth be manufactured and distributed by DNDT under the “Bioassaygen”. brand of products.
A contract-manufacturer for the product has already been identified in Europe, and sale and distribution arrangements are currently being made in several European countries.
Bioassaygen Gel, is a cosmeceutical that, when applied directly to the Skin, reduces wrinkles and promotes natural skin re-genesis.
Bioassaygen Cosmetic Mask is a stabilizing platform for the sustained use of Bioassaygen Gel. It is used mainly for vanity applications.
Bioassaygen Bio-Skin is a scientifically developed Skin Replacement Bandage.
Bioassaygen Delivery Gel (a serum) is a biologically-active catalyst that, when applied, creates an environment which accelerates natural skin re-genesis. Generally used in conjunction with Bioassaygen Bio-Skin.
The patented Skin Replacement Bandage and Delivery Gel products are designed to replace natural skin that may have been lost due to burns, frostbite, pressure sores, etc. The Bio-Skin technology is designed to replaces traditional skin grafting by using synthetically-created skin in lieu of natural skin.
DNDT has enormous potential for future growth and the technical set-up leads me to believe that readers could see Massive Gains on Monday's trading session! I will be sending more updates over the weekend for now continue your research below:
DNDT Website: http://www.dndtechnologies.com/index.html
DNDT Chart: http://www.otcmarkets.com/stock/DNDT/chart
DNDT News: http://www.otcmarkets.com/stock/DNDT/news
It'll take more than that onr promoter to move DNDT.
From their history, they never seem to be comped for their promos.
http://stockpromoters.com/View-Promotions-By-Promoter.aspx?promoter=otc+rockstar&x=7&y=6
And there aren't many.
The last promo they did was for YGDC, in conjunction with others, on 12/20. They may be associated with other promo sites.
Well they got more going for them then some companies I've seen promoted as of late, like AC_RI which got pumped by StockMister and is nothing but an empty shell...lol.
DNDT has Cinutri as a done deal and Bioassaygen as well but we still don't have many details about that one.
IMO it's too early to promote DND, all they need is communication, this share structure and the Bioassaygen potential alone is enough to propel this to higher levels without the need for any stock promotion.
However, he mentioned that they are not getting compensated for the promotion so the company itself has nothing to do with it.
If someone is pumping it then DND mgmt should wake the hell up and take advantage by issuing a PR or shareholder update to support any additional awareness........otherwise any increase in pps will not be sustainable IMO.
In order for a stock to be promoted, wouldn't they at least need some semblance of a company to promote?
DNDT
This stock is being promoted starting Monday on otcrockstar.com newsletter. Not getting paid for promo either.
And Winter doesn't even officially start until tomorrow. Seriously folks, are we going to have to wait for the next Q or the end of year statement before we get any more news?
I know Peters only was supposed to be with DNDT for one year.. his time is up and we have a new acquisition, doesn't anyone over there want to the company to make money and the stock to rise in value. I thought that was the reason for the reverse split. Humph.
I think DND management is in hibernation for the Winter.
These small trades have always been happening. You were just never able to see them until recently.
http://www.nasdaqtrader.com/TraderNews.aspx?id=dtn2013-34
Someone actually sold 50 shares today at .01? What is that 50 cents. What a strange strange stock. come on guys. Spend $10.00 to make get .05. REally ??
Can you belie e tha 400 sale today. What is with that? I understand small buys but not the sales.
Agreed, they just can't seem to understand that showing even the smallest semblance of progress would go a long way in helping restore investor confidence again........ might even help the dismal pps as well.
We can only hope that the new president is competent and actually knows what it takes to run a public company correctly. I don't think those involved in DND right now could even run a lemonade stand successfully.
I would love to hear from the company. Even a promised website for the new products would help so much.
One would think.
It sounds to me like Ashlin essentially traded 3.7M shares of RAFA for 20M shares of DNDT, right now that's looking like a seriously boneheaded move but hopefully they know something we don't.
I mean from what little we have been told we can see the potential of the Bioassaygen products, however, can DND management capitalize on them....who knows.
Yep/
But I keep thinking if someone was willing to drop 2 million into this, it must have potential.
Don't you think?
I think Helen Keller had better communication skills than DNDT management.
Just sent Justine at the stock transfer company a query. Can't get them to return calls so thought I would try something new.
DNDT is so quiet.
What a little PR, and a good day of volume could do to this stock. Please. help us out a little
I honestly wonder if it is the CEO or the board. I have felt, at times, that Peters wanted to communicate more, but was blocked.
One would think but with DND you never know, many of their decisions often leave you scratching your head. It's always been that way from the beginning though, not just with DND but JAQ and RAF as well, sometimes your just like "what were they thinking??"
One of these days they will wake up and finally start communicating again, the stock is never going anywhere until they do. Of course when they do finally get around to it, they will already have missed out on months when they could have been generating a buzz for the new products and/or raising capital.
Sometimes I wonder if it's like the blind leading the blind when it comes to DND.....I can only hope the new incoming CEO can actually see.....lol.
Will DNDT have to actually announce the new president when that happens. We are starving for news here.
Yes. The new products look great and th float is low so this will move fast as we anticipate news
Even better lol! Acquisitions! :)
O/S is actually 24M now, 20m of that is restricted and went to Ashlin Global in August for the $2M Bioassaygen asset.
The asset is the distribution rights to a line of Russian developed products, one of which, Bio-Skin, has been featured on CNN.
~DNDT~ could hit .20 based on those #'s below :)
$56k in NET PROFITS for period ending Sept '13
4.4M O/S :) Easy money at these prices $$$
Welcome aboard, could definitely use some of that magic you brought to LE_OM here. :)
Still waiting on more details/developments from management but I like the potential with the new product line for sure.
~DNDT~ bought this dip to .02
My guess is that changing the name was not a DNDT idea
High fives. Finally going towards the right direction
High fives guys! Lets celebrate. I am more than willing to guard the bid right now as we await news
Pretty surprised that it got that low and stayed there so long, actually.
Hopefully, $.02 and lower proves to be a good price point.
That is true, especially given the share structure and that the Bioassaygen distribution rights are valued at $2M alone.
True. I am just glad I picked some up down there so in one of my accounts I am finally greenN.
From the standpoint of the company's mc, the adjustment in the sp today really just brings it back to something a bit more normal.
$.01 wasn't realistic.
That's a thought that had crossed my mind.
In the last PR they claimed that discussions were under way for distributing the products in Eastern Europe, we already know GBS is distributing them there.
In fact GBS also just secured the domain name hyamatrix.eu recently with the website in English, German, Hungarian and Spanish. They are rolling out the products big time so if they are working with DND that would be very promising.
If they are a DND competitor though then were screwed because it's going to take DND forever to get around to making any headway...lol.
Not to mention they are being sold as Hyamatrix from GBS, an already well known name, unlike DND who changed the name for whatever reason.
Agree. I wish I felt they read the boards maybe they will today with the price change. And if they are reading I sure hope they will provide us an update as we patient longs deserve an update.
If there is already a new president, and they are not quite ready to give shareholders a PR about it, then they could at least update OTC Markets and/or the Nevada SOS and tell us who the heck it is.
I don't buy that Peters is always out of the country working. I can guarantee you that if there were a sudden demand for DND stock and a bunch of big bids showed up, someone from the company is watching close enough to fill those bids.
Whether it be Peters, Rosen, or some other insider, whatever the case, someone from the company always pays attention to whats happening with the stock IMO.
I hate to break it to them but NOTHING real is going to happen with the stock price until they start communicating with the shareholders and executing a solid business plan. No more of this Best Balms or Corrib crap that doesn't pan out.
Thanks for reposting. It has been a month now and honestly I was expecting some news. If you hear anything more. Keep posting please. I did not get a response to my last post
I know Peterson does not want to keep the job but someone said he knew the next prez was already working on stuff
Maybe they can team up on distribution. If they can get Europe also
A couple 1K paint jobs is nothing to get excited about but it does show it can move with ease if/when they ever get back to business again.
Hell at this rate GBS is going to have the products distributed all over Europe, whilst DNDT in the meantime is still sitting around scratching their arses trying to figure out who is going to be the new president of the company.
http://www.gbs-europe.com
Followers
|
72
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
8771
|
Created
|
06/16/04
|
Type
|
Free
|
Moderators |
DND Technologies, Inc.
Tel: 1-800-341-8940
Fax: 212-537-9088
954 Lexington Avenue, Suite 505
New York, NY 10021
E-Mail: info@dndtechnologies.com
Website: http://www.dndtechnologies.com/
Press (PR's/News): http://www.dndtechnologies.com/press_release.html
DNDT has already taken a number of strategic and financial positions in research and development activities in both on-going and start-up businesses. In most of these areas, basic research has been completed and DNDT is in the process of obtaining intellectual property rights. Announcements will be made here as soon as project-specific funds and/or strategic partnerships are secured.
As a holding company, DNDT does not have any operations, activities, or other active business. Instead, it owns assets. DNDT anticipates that, as it makes additional acquisitions, these assets will be shares of stock in other corporations, limited liability companies, limited partnerships, private equity funds, hedge funds, publicly traded stocks, bonds, real estate, song rights, brand names, patents, trademarks, copyrights, and other assets that have value.
Recent Acquistion
DND Technologies (www.dndtechnologies.com) has acquired all the inventory, other assets and the exclusive rights to distribute a pharmaceutical line of products in the United States, Canada and Europe. Rebranded by DNDT, the inventory of products includes Bioassaygen Gel, Bioassaygen Cosmetic Mask, Bioassaygen Bio-Skin, and Bioassaygen Delivery Gel, all of which will henceforth be manufactured and distributed by DNDT under the “Bioassaygen”. brand of products. A contract-manufacturer for the product has already been identified in Europe, and sale and distribution arrangements are currently being made in several European countries.
The patented Skin Replacement Bandage and Delivery Gel products are designed to replace natural skin that may have been lost due to burns, frostbite, pressure sores, etc. The Bio-Skin technology is designed to replaces traditional skin grafting by using synthetically-created skin in lieu of natural skin.
Share Structure
Shares Outstanding | 24,402.246 | a/o Jul 15, 2013 |
Authorized Share |
Company Officers/Contacts
President | Jonathan Peters |
Secretary | Janet John |
Transfer Agent(s)
Action Stock Transfer Corporation
2469 E. Fort Union Blvd. #214
Salt Lake City, UT 84121
+1801 274 1088
The Transfer Agent is registered under the Exchange Act
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |